Cargando…
Efficacy of PolyMPC–DOX Prodrugs in 4T1 Tumor-Bearing Mice
[Image: see text] We report the in vivo efficacy, in tumor-bearing mice, of cancer prodrugs consisting of poly(methacryloyloxyethyl phosphorylcholine) (polyMPC) conjugated to doxorubicin (DOX). Our synthesis of polyMPC–DOX conjugates established prodrugs with tunable drug loading, pH sensitive relea...
Autores principales: | McRae Page, Samantha, Henchey, Elizabeth, Chen, Xiangji, Schneider, Sallie, Emrick, Todd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018119/ https://www.ncbi.nlm.nih.gov/pubmed/24750072 http://dx.doi.org/10.1021/mp500009r |
Ejemplares similares
-
TPGS2000-DOX Prodrug Micelles for Improving Breast Cancer Therapy
por: Tang, Lan, et al.
Publicado: (2021) -
PhAc-ALGP-Dox, a Novel Anticancer Prodrug with Targeted Activation and Improved Therapeutic Index
por: Casazza, Andrea, et al.
Publicado: (2022) -
A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer
por: Houba, P H J, et al.
Publicado: (2001) -
The construction of the novel magnetic prodrug Fe(3)O(4)@DOX and its antagonistic effects on hepatocarcinoma with low toxicity
por: Li, Jun, et al.
Publicado: (2020) -
MPC construction techniques
Publicado: (1971)